NFKB1 and diabetes mellitus: In a rat model of diabetes, mangiferin has been shown to promote wound healing caused by diabetes by upregulating the expression of Nrf2, VEGF, and PI3K and downregulating the expression of TNFα and NF-κB p65 [65].